In our study, using omalizumab resulted in rapid improvement of asthma and other IgE-mediated concomitant allergic symptoms (allergic rhinitis and food allergy) and reduced the use of hormones and associated medications (Hutyrová et al., 2018; Liu and Yin, 2019). The gene discussed is IGHE; the disease is asthma.